Amiloride, a specific drug for hypertension in black people with T594M variant?

Emma H. Baker, Ajay Duggal, Yanbin Dong, Nicola J. Ireson, Monique Wood, Nirmala D. Markandu, Graham A. MacGregor

Research output: Contribution to journalArticle

70 Citations (Scopus)

Abstract

The T594M polymorphism of the epithelial sodium channel is found in ≈5% of people of African origin and is significantly associated with high blood pressure. Although the T594M polymorphism could increase renal sodium absorption through affected channels, it is not known whether this polymorphism causes hypertension. Amiloride specifically inhibits overactive sodium channels and effectively controls blood pressure in Liddle's syndrome, in which hypertension is caused by separate epithelial sodium channel mutations. The aim of this study was to determine whether amiloride was effective in lowering blood pressure in individuals with the T594M polymorphism. In an open, controlled study, 14 black hypertensive individuals with the T594M polymorphism were withdrawn from their usual medication and treated with amiloride. On entry to the study, individuals taking a mean of 2 drugs had blood pressure of 142/89±3/3 mm Hg. Amiloride alone (10 mg BID) controlled blood pressure effectively to the same level (140/91±4/2 mmHg). When amiloride was withdrawn for 2 weeks, there was a large increase in blood pressure of 17/8±4/2 mm Hg (systolic, P<0.05; diastolic, P<0.01). On restarting amiloride, blood pressure was again controlled to 140/88±6/2 mm Hg. These results demonstrate that 10 mg BID amiloride is effective in controlling blood pressure in hypertensive individuals of African origin who have the T594M polymorphism. Our study supports the concept that the T594M polymorphism contributes to the elevation of blood pressure and suggests that consideration should be given to the use of amiloride in affected individuals.

Original languageEnglish (US)
Pages (from-to)13-17
Number of pages5
JournalHypertension
Volume40
Issue number1
DOIs
StatePublished - Jul 22 2002
Externally publishedYes

Fingerprint

Amiloride
Blood Pressure
Hypertension
Pharmaceutical Preparations
Epithelial Sodium Channels
Liddle Syndrome
Sodium Channels
Sodium
Mutation

Keywords

  • Blacks
  • Epithelium
  • Hypertension, essential
  • Polymorphism
  • Sodium channel

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Baker, E. H., Duggal, A., Dong, Y., Ireson, N. J., Wood, M., Markandu, N. D., & MacGregor, G. A. (2002). Amiloride, a specific drug for hypertension in black people with T594M variant? Hypertension, 40(1), 13-17. https://doi.org/10.1161/01.HYP.0000022570.02119.75

Amiloride, a specific drug for hypertension in black people with T594M variant? / Baker, Emma H.; Duggal, Ajay; Dong, Yanbin; Ireson, Nicola J.; Wood, Monique; Markandu, Nirmala D.; MacGregor, Graham A.

In: Hypertension, Vol. 40, No. 1, 22.07.2002, p. 13-17.

Research output: Contribution to journalArticle

Baker, EH, Duggal, A, Dong, Y, Ireson, NJ, Wood, M, Markandu, ND & MacGregor, GA 2002, 'Amiloride, a specific drug for hypertension in black people with T594M variant?', Hypertension, vol. 40, no. 1, pp. 13-17. https://doi.org/10.1161/01.HYP.0000022570.02119.75
Baker, Emma H. ; Duggal, Ajay ; Dong, Yanbin ; Ireson, Nicola J. ; Wood, Monique ; Markandu, Nirmala D. ; MacGregor, Graham A. / Amiloride, a specific drug for hypertension in black people with T594M variant?. In: Hypertension. 2002 ; Vol. 40, No. 1. pp. 13-17.
@article{3c9c7b6d4daa4a7ea1606e5dc888c33a,
title = "Amiloride, a specific drug for hypertension in black people with T594M variant?",
abstract = "The T594M polymorphism of the epithelial sodium channel is found in ≈5{\%} of people of African origin and is significantly associated with high blood pressure. Although the T594M polymorphism could increase renal sodium absorption through affected channels, it is not known whether this polymorphism causes hypertension. Amiloride specifically inhibits overactive sodium channels and effectively controls blood pressure in Liddle's syndrome, in which hypertension is caused by separate epithelial sodium channel mutations. The aim of this study was to determine whether amiloride was effective in lowering blood pressure in individuals with the T594M polymorphism. In an open, controlled study, 14 black hypertensive individuals with the T594M polymorphism were withdrawn from their usual medication and treated with amiloride. On entry to the study, individuals taking a mean of 2 drugs had blood pressure of 142/89±3/3 mm Hg. Amiloride alone (10 mg BID) controlled blood pressure effectively to the same level (140/91±4/2 mmHg). When amiloride was withdrawn for 2 weeks, there was a large increase in blood pressure of 17/8±4/2 mm Hg (systolic, P<0.05; diastolic, P<0.01). On restarting amiloride, blood pressure was again controlled to 140/88±6/2 mm Hg. These results demonstrate that 10 mg BID amiloride is effective in controlling blood pressure in hypertensive individuals of African origin who have the T594M polymorphism. Our study supports the concept that the T594M polymorphism contributes to the elevation of blood pressure and suggests that consideration should be given to the use of amiloride in affected individuals.",
keywords = "Blacks, Epithelium, Hypertension, essential, Polymorphism, Sodium channel",
author = "Baker, {Emma H.} and Ajay Duggal and Yanbin Dong and Ireson, {Nicola J.} and Monique Wood and Markandu, {Nirmala D.} and MacGregor, {Graham A.}",
year = "2002",
month = "7",
day = "22",
doi = "10.1161/01.HYP.0000022570.02119.75",
language = "English (US)",
volume = "40",
pages = "13--17",
journal = "Hypertension",
issn = "0194-911X",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Amiloride, a specific drug for hypertension in black people with T594M variant?

AU - Baker, Emma H.

AU - Duggal, Ajay

AU - Dong, Yanbin

AU - Ireson, Nicola J.

AU - Wood, Monique

AU - Markandu, Nirmala D.

AU - MacGregor, Graham A.

PY - 2002/7/22

Y1 - 2002/7/22

N2 - The T594M polymorphism of the epithelial sodium channel is found in ≈5% of people of African origin and is significantly associated with high blood pressure. Although the T594M polymorphism could increase renal sodium absorption through affected channels, it is not known whether this polymorphism causes hypertension. Amiloride specifically inhibits overactive sodium channels and effectively controls blood pressure in Liddle's syndrome, in which hypertension is caused by separate epithelial sodium channel mutations. The aim of this study was to determine whether amiloride was effective in lowering blood pressure in individuals with the T594M polymorphism. In an open, controlled study, 14 black hypertensive individuals with the T594M polymorphism were withdrawn from their usual medication and treated with amiloride. On entry to the study, individuals taking a mean of 2 drugs had blood pressure of 142/89±3/3 mm Hg. Amiloride alone (10 mg BID) controlled blood pressure effectively to the same level (140/91±4/2 mmHg). When amiloride was withdrawn for 2 weeks, there was a large increase in blood pressure of 17/8±4/2 mm Hg (systolic, P<0.05; diastolic, P<0.01). On restarting amiloride, blood pressure was again controlled to 140/88±6/2 mm Hg. These results demonstrate that 10 mg BID amiloride is effective in controlling blood pressure in hypertensive individuals of African origin who have the T594M polymorphism. Our study supports the concept that the T594M polymorphism contributes to the elevation of blood pressure and suggests that consideration should be given to the use of amiloride in affected individuals.

AB - The T594M polymorphism of the epithelial sodium channel is found in ≈5% of people of African origin and is significantly associated with high blood pressure. Although the T594M polymorphism could increase renal sodium absorption through affected channels, it is not known whether this polymorphism causes hypertension. Amiloride specifically inhibits overactive sodium channels and effectively controls blood pressure in Liddle's syndrome, in which hypertension is caused by separate epithelial sodium channel mutations. The aim of this study was to determine whether amiloride was effective in lowering blood pressure in individuals with the T594M polymorphism. In an open, controlled study, 14 black hypertensive individuals with the T594M polymorphism were withdrawn from their usual medication and treated with amiloride. On entry to the study, individuals taking a mean of 2 drugs had blood pressure of 142/89±3/3 mm Hg. Amiloride alone (10 mg BID) controlled blood pressure effectively to the same level (140/91±4/2 mmHg). When amiloride was withdrawn for 2 weeks, there was a large increase in blood pressure of 17/8±4/2 mm Hg (systolic, P<0.05; diastolic, P<0.01). On restarting amiloride, blood pressure was again controlled to 140/88±6/2 mm Hg. These results demonstrate that 10 mg BID amiloride is effective in controlling blood pressure in hypertensive individuals of African origin who have the T594M polymorphism. Our study supports the concept that the T594M polymorphism contributes to the elevation of blood pressure and suggests that consideration should be given to the use of amiloride in affected individuals.

KW - Blacks

KW - Epithelium

KW - Hypertension, essential

KW - Polymorphism

KW - Sodium channel

UR - http://www.scopus.com/inward/record.url?scp=0036314225&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036314225&partnerID=8YFLogxK

U2 - 10.1161/01.HYP.0000022570.02119.75

DO - 10.1161/01.HYP.0000022570.02119.75

M3 - Article

VL - 40

SP - 13

EP - 17

JO - Hypertension

JF - Hypertension

SN - 0194-911X

IS - 1

ER -